Agonist treatment did not affect association of mu opioid receptors with lipid rafts and cholesterol reduction had opposite effects on the receptor-mediated signaling in rat brain and CHO cells
- 1 December 2007
- journal article
- Published by Elsevier in Brain Research
- Vol. 1184, 46-56
- https://doi.org/10.1016/j.brainres.2007.09.096
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Cholesterol reduction by methyl-β-cyclodextrin attenuates the delta opioid receptor-mediated signaling in neuronal cells but enhances it in non-neuronal cellsBiochemical Pharmacology, 2007
- Rafts defined: a report on the Keystone symposium on lipid rafts and cell functionJournal of Lipid Research, 2006
- Localization of the κ Opioid Receptor in Lipid RaftsThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Adenylyl Cyclase Superactivation Induced by Long-Term Treatment with Opioid Agonist Is Dependent on Receptor Localized within Lipid Rafts and Is Independent of Receptor InternalizationMolecular Pharmacology, 2006
- Caveolae — from ultrastructure to molecular mechanismsNature Reviews Molecular Cell Biology, 2003
- Functional Role of a Conserved Motif in TM6 of the Rat μ Opioid Receptor: Constitutively Active and Inactive Receptors Result from Substitutions of Thr6.34(279) with Lys and AspBiochemistry, 2001
- Molecular tinkering of G protein-coupled receptors: an evolutionary successThe EMBO Journal, 1999
- Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the µ-opioid-receptor geneNature, 1996
- Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surfacePublished by Elsevier ,1992
- Anatomy of CNS opioid receptorsTrends in Neurosciences, 1988